234 results
Page 6 of 12
6-K
EX-99.1
evdr0d4
13 May 20
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment and the BLU-5937 Program
7:00am
6-K
EX-99.1
hisjser5mr9f
7 Apr 20
Bellus HEALTH 2019 ANNUAL REPORT
9:59am
6-K
EX-99.1
a83ooosrvj1i
6 Apr 20
BELLUS Health Announces Completion of Dosing in Phase 2 RELIEF Trial with BLU-5937 for the Treatment of Refractory Chronic Cough
5:02pm
6-K
EX-99.1
le8r kvycist2zz8
25 Mar 20
BELLUS Health Announces Closing of Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovations
2:25pm
6-K
EX-99.2
8icz rwk506ll
23 Mar 20
Current report (foreign)
8:11am
SUPPL
qlk05 axd2pij47szfk
23 Mar 20
Supplemental materials (foreign)
7:06am
6-K
EX-99.1
41s xzse6uq
19 Mar 20
BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
40-F
u2f33izbotvu0n 6al
27 Feb 20
Annual report (Canada)
5:13pm
40-F
EX-99.2
s5lfytpt9x7
27 Feb 20
Annual report (Canada)
5:13pm
40-F
EX-99.3
8srzjftbwz8y j8yi
27 Feb 20
Annual report (Canada)
5:13pm
40-F
EX-99.1
i9zeo4pmuyv81b394896
27 Feb 20
Annual report (Canada)
5:13pm
6-K
EX-99.1
86o e1b6j
27 Feb 20
BELLUS Health Reports Full Year 2019 Financial Results and Business Highlights on BLU-5937
5:00pm
F-10/A
lbxkqnyrn3we843uisq
17 Jan 20
Registration of securities (Canada) (amended)
4:21pm
F-10
EX-4.2
vjglwp60
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.3
d7zdnosalpwqfz
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
p4tvxq6s lxqalwr2
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.1
q4dg1sz
20 Dec 19
Registration of securities (Canada)
4:03pm
6-K
EX-99.2
dsou2k
14 Nov 19
Condensed Consolidated Interim Financial Statements of
3:35pm
6-K
EX-99.4
f7p 3hrjy0i4u06x
14 Nov 19
Condensed Consolidated Interim Financial Statements of
3:35pm
6-K
EX-99.3
pehkn4kafpf412ed
14 Nov 19
Condensed Consolidated Interim Financial Statements of
3:35pm